RAMM Pharma CorpCanadian Securities Exchange:RAMM
- LAST PRICE0.0600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0450/ 30
- Ask / Lots0.0600/ 40
- Open / Previous Close0.0000 / 0.0600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | RAMM |
|---|
Mar 28, 2024
RAMM Pharma Corp. Announces Corporate Update, from 3:49PM ET on Thursday Mar 28, 2024 by Dow Jones
3:49PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
RAMM Pharma Corp | 7.2M | -0.9x | --- |
StageZero Life Sciences Ltd | 4.9M | -0.2x | --- |
Awakn Life Sciences Corp | 4.5M | -1.0x | --- |
Innovotech Inc | 5.1M | -22.1x | --- |
Willow Biosciences Inc | 11.5M | -0.9x | --- |
Bright Minds Biosciences Inc | 7.3M | -0.9x | --- |
Company Information
RAMM Pharma Corp. is a Canada-based company that is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other hemp-based products with a diversified international production and sales platform. The Company operates a pharmaceutical and medical product business in Uruguay that has developed several medically registered and approved plant-derived cannabinoid pharmaceutical products that have been authorized for sale and/or use in several Latin American countries. The Company has a pipeline of products, including registered hemp-based nutrition and specialized veterinary products, in various stages of approval and development, which are produced at its formulation facility in Montevideo, Uruguay. The Company's brands include NettaPet and NettaVet. Its subsidiaries include Canapar Corp., HemPoland S.p. Z.o.o., Medic Plast SA, Yurelan SA, Glediser SA and RAMM Pharma Holdings Corp.
Contact Information
- Headquarters
- 82 Richmond St. ETORONTO, ON, Canada M5C 1P1
- Phone
- 416-848-7744
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.2M |
|---|---|
Revenue (TTM) | $4.7M |
Shares Outstanding | 119.4M |
RAMM Pharma Corp does not pay a dividend. | |
Beta | -0.40 |
EPS | $-0.07 |
Book Value | $0.25 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -168.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
